SPARC receives Priority Review Voucher associated with Sezaby approval EP News Bureau Feb 3, 2026 Sun Pharma Advanced Research Company (SPARC) announced that the United States Food and Drug Administration (FDA) has granted a…
FDA discontinue rare pediatric disease designation program despite increase in RPD approvals EP News Bureau Jul 22, 2025 Due to concerns over its effectiveness, the US Congress did not renew the RPDD program and began to close it in late 2024
